Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Rosato

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Angewandte Chemie (International Ed. in English)|November 18, 2022
Neutralizing the Impact of the Virulence Factor LecA from Pseudomonas aeruginosa on Human Cells with New Glycomimetic InhibitorsEva Zahorska, Francesca Rosato, Kai Stober, et al.
Cells|July 29, 2023
A Shiga Toxin B-Subunit-Based Lectibody Boosts T Cell Cytotoxicity towards Gb3-Positive Cancer CellsJana Tomisch, Vincent Busse, Francesca Rosato, et al.
Communications Biology|September 12, 2022
The choanoflagellate pore-forming lectin SaroL-1 punches holes in cancer cells by targeting the tumor-related glycosphingolipid Gb3Simona Notova, François Bonnardel, Francesca Rosato, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 11, 2008
Effects of lanreotide Autogel on growth hormone, insulinlike growth factor 1, and tumor size in acromegaly: a 1-year prospective multicenter studyRoberto Attanasio, Roberto Lanzi, Marco Losa, et al.
Journal for Immunotherapy of Cancer|October 28, 2025
Combination of a novel TCR Vβ chain-directed selective T cell activator with standard of care therapy for head and neck cancer improves antitumor responses and promotes regression of checkpoint-refractory tumor modelsFrancesca Rosato, Ginette Santiago-Sanchez, Kellsye P Fabian, et al.
Frontiers in Immunology|June 19, 2026
Docetaxel enhances Vβ-directed T-cell activation and antitumor immunity mediated by a bifunctional TCR agonist in breast and prostate cancer modelsJonelle K Lee, Kellsye P Fabian, Ginette S Santiago-Sanchez, et al.
ACS Nano|May 13, 2026
Engineered Coiled-Coils Convert Cholera Toxin B-Pentamers into Programmable Membrane FusogensWenyue Dai, Erik Kempmann, Francesca Rosato, et al.
Journal for Immunotherapy of Cancer|July 1, 2026
PARP inhibition combined with a T-cell receptor β chain-directed antibody fusion molecule drives polyclonal antitumor immunity and tumor regressionGinette Santiago-Sanchez, Francesca Rosato, Kellsye P Fabian, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Angewandte Chemie (International Ed. in English)|November 18, 2022
Neutralizing the Impact of the Virulence Factor LecA from Pseudomonas aeruginosa on Human Cells with New Glycomimetic InhibitorsEva Zahorska, Francesca Rosato, Kai Stober, et al.
Cells|July 29, 2023
A Shiga Toxin B-Subunit-Based Lectibody Boosts T Cell Cytotoxicity towards Gb3-Positive Cancer CellsJana Tomisch, Vincent Busse, Francesca Rosato, et al.
Communications Biology|September 12, 2022
The choanoflagellate pore-forming lectin SaroL-1 punches holes in cancer cells by targeting the tumor-related glycosphingolipid Gb3Simona Notova, François Bonnardel, Francesca Rosato, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 11, 2008
Effects of lanreotide Autogel on growth hormone, insulinlike growth factor 1, and tumor size in acromegaly: a 1-year prospective multicenter studyRoberto Attanasio, Roberto Lanzi, Marco Losa, et al.
Journal for Immunotherapy of Cancer|October 28, 2025
Combination of a novel TCR Vβ chain-directed selective T cell activator with standard of care therapy for head and neck cancer improves antitumor responses and promotes regression of checkpoint-refractory tumor modelsFrancesca Rosato, Ginette Santiago-Sanchez, Kellsye P Fabian, et al.
Frontiers in Immunology|June 19, 2026
Docetaxel enhances Vβ-directed T-cell activation and antitumor immunity mediated by a bifunctional TCR agonist in breast and prostate cancer modelsJonelle K Lee, Kellsye P Fabian, Ginette S Santiago-Sanchez, et al.
ACS Nano|May 13, 2026
Engineered Coiled-Coils Convert Cholera Toxin B-Pentamers into Programmable Membrane FusogensWenyue Dai, Erik Kempmann, Francesca Rosato, et al.
Journal for Immunotherapy of Cancer|July 1, 2026
PARP inhibition combined with a T-cell receptor β chain-directed antibody fusion molecule drives polyclonal antitumor immunity and tumor regressionGinette Santiago-Sanchez, Francesca Rosato, Kellsye P Fabian, et al.
Pageof 2